Sector
HealthcareOpen
₹2,762.9Prev. Close
₹2,749.4Turnover(Lac.)
₹5,585.56Day's High
₹2,790Day's Low
₹2,74052 Week's High
₹3,653.9552 Week's Low
₹2,293.55Book Value
₹254.78Face Value
₹10Mkt Cap (₹ Cr.)
23,196.6P/E
46.54EPS
59.55Divi. Yield
0.8610 May 2024
12:00 AM
AGM
Announcement Date: 10 May, 2024
18 Apr 2025
12:00 AM
Board Meeting
Agenda : Audited Result
25 Apr 2025
12:00 AM
Dividend
Dividend Amount: 6
Record Date: 06 Jun, 2025
Dr Lal PathLabs declared a fourth interim dividend of ₹6 per share for 2025, reflecting its strong cash generation and shareholder remittance focus.
The company declared a third interim dividend of ₹6 per share (60% on a face value of ₹10) for FY25.
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 83.59 | 83.48 | 83.37 | 83.35 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2,050.64 | 1,717.24 | 1,606.5 | 1,388.77 |
Net Worth | 2,134.23 | 1,800.72 | 1,689.87 | 1,472.12 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 1,872.7 | 1,490.55 | 1,273.59 | 1,024.04 |
yoy growth (%) | 25.63 | 17.03 | 24.36 | 16.12 |
Raw materials | -446.31 | -373.9 | -286.86 | -219.31 |
As % of sales | 23.83 | 25.08 | 22.52 | 21.41 |
Employee costs | -320.22 | -257.43 | -232.06 | -175.08 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 459.39 | 374.04 | 302.75 | 255.31 |
Depreciation | -75.31 | -69.77 | -68 | -31.04 |
Tax paid | -115.34 | -93.93 | -79.57 | -87.33 |
Working capital | -358.09 | 332.24 | 134.44 | 87.45 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 25.63 | 17.03 | 24.36 | 16.12 |
Op profit growth | 25.24 | 24.27 | 28.21 | 11.1 |
EBIT growth | 25.47 | 22.51 | 23.92 | 10.42 |
Net profit growth | 22.82 | 25.5 | 32.85 | 10.16 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 2,461.4 | 2,226.6 | 2,016.9 | 2,087.4 | 1,581.3 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 2,461.4 | 2,226.6 | 2,016.9 | 2,087.4 | 1,581.3 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 93.4 | 69.2 | 41.7 | 52.5 | 51.3 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 1,266.5 | 162.98 | 1,23,107.82 | 177.39 | 0.12 | 658.7 | 85.26 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 7,101.5 | 78.77 | 1,02,110.83 | 333.4 | 0.39 | 2,075.3 | 607.44 |
Fortis Healthcare Ltd FORTIS | 790.7 | 465.24 | 59,709.64 | -42.23 | 0.13 | 388.47 | 120.19 |
Narayana Hrudayalaya Ltd NH | 2,073.3 | 98.14 | 42,319.04 | 159.98 | 0.22 | 919.03 | 106.95 |
Aster DM Healthcare Ltd ASTERDM | 596 | 5.25 | 30,911.1 | 61.07 | 19.88 | 573.86 | 79.8 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Chairman
Arvind Lal
Whole-time Director
Vandana Lal
Non Executive Director
Archana Lal Erdmann
Non Executive Director
Rahul Sharma
Independent Director
Somya Satsangi
Independent Director
Rohit Bhasin
Independent Director
Arun Duggal
Independent Director
Gurinder Singh Kalra
Independent Director
RAJIT MEHTA
Company Sec. & Compli. Officer
Vinay Gujral
E-2 Block Sector 18,
Rohini,
New Delhi - 110085
Tel: 91-011-3024 4149
Website: http://www.lalpathlabs.com
Email: [email protected]
Noble Heights 1st Fl,
Plot NH 2 C-1 Block, LSC Janakpuri,
New Delhi - 110058
Tel: 91-11-41410592/93/94
Website: www.linkintime.co.in
Email: [email protected]
Summary
Dr. Lal PathLabs Limited was incorporated as a Private Limited Company with the name Dr. Lal PathLabs Private Limited, on February 14, 1995 at Delhi. The business of the Partnership Firm, Central Clin...
Read More
Reports by Dr Lal Pathlabs Ltd
What is the Dr Lal Pathlabs Ltd share price today?
What is the Market Cap of Dr Lal Pathlabs Ltd?
What is the PE and PB ratio of Dr Lal Pathlabs Ltd?
What is the 52 Week High and Low of Dr Lal Pathlabs Ltd?
What is the CAGR of Dr Lal Pathlabs Ltd?
What is the shareholding pattern of Dr Lal Pathlabs Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
